Suppr超能文献

1型人类免疫缺陷病毒逆转录酶表型齐多夫定耐药性与突变模式的相关性:已确定突变的解读及208、211和214密码子新多态性的特征分析

Correlation of phenotypic zidovudine resistance with mutational patterns in the reverse transcriptase of human immunodeficiency virus type 1: interpretation of established mutations and characterization of new polymorphisms at codons 208, 211, and 214.

作者信息

Stürmer Martin, Staszewski Schlomo, Doerr Hans-Wilhelm, Larder Brendan, Bloor Stuart, Hertogs Kurt

机构信息

Zentrum der Inneren Medizin. Institut für Medizinische Virologie, J. W. Goethe Universität, Frankfurt, Germany.

出版信息

Antimicrob Agents Chemother. 2003 Jan;47(1):54-61. doi: 10.1128/AAC.47.1.54-61.2003.

Abstract

Zidovudine resistance (ZDV-R) is associated with classic genotypic changes at codons 41, 67, 70, 210, 215, and 219 of the human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) gene as well as with the multinucleoside resistance (MNR) complexes (Q151M MNR complex; 6-bp insertion/A62V complex). In addition, enhanced resistance to ZDV in the context of the classic ZDV mutations plus the M184V mutation has been associated with additional mutations at positions 208, 211, 214, and 333. In this study we investigated phenotypic ZDV-R determined by a recombinant virus assay (Antivirogram; Virco) in 223 clinical samples in relation to the above genotypic changes. 150 out of 223 clinical samples had the M184V mutation. Phenotypic ZDV-R ranged from 0.3- to 5,338-fold. Sixteen samples (15 with high ZDV-R ranging from 90- to 3,571-fold) contained MNR-associated patterns. Analysis of classic mutational patterns broadly demonstrated increasing ZDV-R with increasing number of ZDV mutations. A comparable correlation was obtained when ZDV-R was analyzed only relative to the T215Y/F mutation. Site-directed mutagenesis experiments investigating the influence of the additional mutations H208Y, R211K, and L214F on ZDV-R resulted in a 7.4- or 21-fold increase in ZDV-R when the R211K/L214F or H208Y/R211K/L214F mutations, respectively, were added to a highly ZDV-R virus. In the clinical sample data set we analyzed, the combination of R211K/L214F appeared most frequently. The H208Y change was detected only in highly ZDV-R viruses, whereas the G333E/D change was distributed equally. All changes were independent of the M184V mutation. A 2.4- or 8-fold increase in ZDV-R was observed in the clinical samples with high ZDV-R containing the R211K/L214F or H208Y/R211K/L214F mutations, respectively. We have shown that the combination of the additional mutations H208Y, R211K, and L214F in HIV-1 RT may influence ZDV-R and should be considered when assessing ZDV-R.

摘要

齐多夫定耐药性(ZDV-R)与人类免疫缺陷病毒1型(HIV-1)逆转录酶(RT)基因密码子41、67、70、210、215和219处的经典基因型变化以及多核苷耐药性(MNR)复合物(Q151M MNR复合物;6碱基插入/A62V复合物)相关。此外,在经典的齐多夫定突变加上M184V突变的情况下,对齐多夫定的耐药性增强与208、211、214和333位点的额外突变有关。在本研究中,我们通过重组病毒检测法(抗病毒谱分析;Virco公司)在223份临床样本中研究了与上述基因型变化相关的表型齐多夫定耐药性。223份临床样本中有150份存在M184V突变。表型齐多夫定耐药性范围为0.3至5338倍。16份样本(15份齐多夫定耐药性高,范围为90至3571倍)含有与MNR相关的模式。对经典突变模式的分析大致表明,随着齐多夫定突变数量的增加,齐多夫定耐药性增强。仅相对于T215Y/F突变分析齐多夫定耐药性时,也得到了类似的相关性。研究额外突变H208Y、R211K和L214F对齐多夫定耐药性影响的定点诱变实验表明,当分别将R211K/L214F或H208Y/R211K/L214F突变添加到高齐多夫定耐药性病毒中时,齐多夫定耐药性增加了7.4倍或21倍。在我们分析的临床样本数据集中,R211K/L214F组合出现得最为频繁。仅在高齐多夫定耐药性病毒中检测到H208Y变化,而G333E/D变化分布均匀。所有变化均与M184V突变无关。在含有R211K/L214F或H208Y/R211K/L214F突变的高齐多夫定耐药性临床样本中,分别观察到齐多夫定耐药性增加了2.4倍或8倍。我们已经表明,HIV-1 RT中额外突变H208Y、R211K和L214F的组合可能影响齐多夫定耐药性,在评估齐多夫定耐药性时应予以考虑。

相似文献

9
Effect of the Q207D mutation in HIV type 1 reverse transcriptase on zidovudine susceptibility and replicative fitness.
J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):20-3. doi: 10.1097/01.qai.0000172369.82456.36.

引用本文的文献

4
Differential in vitro kinetics of drug resistance mutation acquisition in HIV-1 RT of subtypes B and C.
PLoS One. 2012;7(10):e46622. doi: 10.1371/journal.pone.0046622. Epub 2012 Oct 3.
6
Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy.
AIDS Res Hum Retroviruses. 2011 Jan;27(1):71-80. doi: 10.1089/aid.2010.0050. Epub 2010 Oct 21.
9
Human immunodeficiency virus polymorphisms and zidovudine resistance.
Antimicrob Agents Chemother. 2003 Aug;47(8):2714; author reply 2714-5. doi: 10.1128/AAC.47.8.2714-2715.2003.

本文引用的文献

1
Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs).
Cell Mol Life Sci. 2000 Sep;57(10):1408-22. doi: 10.1007/PL00000626.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验